 |
|
Montreal researchers identify defects of immune cells
June 22, 2006Immune cells that give rise to a fungal infection commonly found in HIV patients
Montréal — Researchers at Université de Montréal and the Institut de recherches cliniques de Montréal (IRCM) have successfully identified a defective immune cell population that determines susceptibility to candidiasis, a common and often debilitating infection in individuals infected with the human immunodeficiency virus (HIV). These findings, revealed using a model of candidiasis in transgenic mice expressing HIV developed by the same research group, represents a milestone in developing a treatment for the infection and, eventually, preventing it. They are described in an article of the July 1st issue of The Journal of Immunology.
Oral and esophageal Candida albicans infections, which often affect individuals infected with HIV, may limit food consumption and lead to weight loss, threatening patients' general health and well-being. Of added concern, treatment of candidiasis in these patients is often complicated by strains of Candida albicans resistant to conventional antifungal therapies. The research project was carried out jointly by Dr. Louis de Repentigny, Director of the Medical Mycology Laboratory and Professor in the Department of Microbiology and Immunology at the Faculty of Medicine of Université de Montréal, and at CHU Sainte-Justine, and Dr. Paul Jolicoeur, Director of the Molecular Biology Research Unit at the Institut de recherches cliniques de Montréal (IRCM), researcher in the Department of Microbiology and Immunology at the Faculty of Medicine of Université de Montréal, associate member of the McGill University Faculty of Medicine and holder of the Canada Research Chair on Infectious and Parasitic Diseases and Dr Zaher Hanna, Associate Director in the same Unit, researcher in the Department of Medicine at the Faculty of Medicine of Université de Montréal, associate member of the McGill University Division of Experimental Medicine.
Drs de Repentigny, JolicÅ"ur and Hanna have for the first time succeeded in demonstrating that defective CD4+ T lymphocytes primarily determine the susceptibility to oral candidiasis in transgenic mice expressing HIV-1 and developing an AIDS-like disease. Findings from this research further indicated that a diminution and functional defects of both dendritic cells and CD4+ cells cause susceptibility to candidiasis in these transgenic mice by preventing T lymphocyte mediated acquired immunity to Candida albicans. The results also showed extensive perturbations in the production of cytokines required for protection against oral candidiasis in the transgenic mice.
"These findings regarding the specific immune defects which trigger candidiasis are very promising," explains Dr. de Repentigny. "This new knowledge will be instrumental in designing more powerful and effective treatments, which will directly improve the health status of HIV-infected patients who suffer from candidiasis. Defective CD4+ T lymphocytes have long been suspected to be the leading cause of candidiasis, however, it never had been directly demonstrated. Now, they become designated targets for the development of novel treatments not only for candidiasis but other mucosal infections."
"Secondary infections are the major cause of morbidity and mortality in people infected by HIV/AIDS. Fungal infection due to candidiasis is one of these debilitating conditions," said Dr. Bhagirath Singh, Scientific Director of the Canadian Institutes of Health Research (CIHR) Institute of Infection and Immunity. "This work provides a new understanding of why candidiasis is not controlled by the body's immune cells, particularly the CD4+ T lymphocytes. It will also help us to develop better treatments to prevent these opportunistic infections in HIV patients."
University of Montreal
Drs de Repentigny, JolicÅ"ur and Hanna have for the first time succeeded in demonstrating that defective CD4+ T lymphocytes primarily determine the susceptibility to oral candidiasis in transgenic mice expressing HIV-1 and developing an AIDS-like disease. Findings from this research further indicated that a diminution and functional defects of both dendritic cells and CD4+ cells cause susceptibility to candidiasis in these transgenic mice by preventing T lymphocyte mediated acquired immunity to Candida albicans. The results also showed extensive perturbations in the production of cytokines required for protection against oral candidiasis in the transgenic mice.
"These findings regarding the specific immune defects which trigger candidiasis are very promising," explains Dr. de Repentigny. "This new knowledge will be instrumental in designing more powerful and effective treatments, which will directly improve the health status of HIV-infected patients who suffer from candidiasis. Defective CD4+ T lymphocytes have long been suspected to be the leading cause of candidiasis, however, it never had been directly demonstrated. Now, they become designated targets for the development of novel treatments not only for candidiasis but other mucosal infections."
"Secondary infections are the major cause of morbidity and mortality in people infected by HIV/AIDS. Fungal infection due to candidiasis is one of these debilitating conditions," said Dr. Bhagirath Singh, Scientific Director of the Canadian Institutes of Health Research (CIHR) Institute of Infection and Immunity. "This work provides a new understanding of why candidiasis is not controlled by the body's immune cells, particularly the CD4+ T lymphocytes. It will also help us to develop better treatments to prevent these opportunistic infections in HIV patients."
University of Montreal
Immune Cells Current Events and Immune Cells News RSSGene mismatch influences success of bone marrow transplants
A commonly inherited gene deletion can increase the likelihood of immune complications following bone marrow transplantation, an international team of researchers reports in the November 22 advance online issue of Nature Genetics.
New findings suggest strategy to help generate HIV-neutralizing antibodies
New discoveries about anti-HIV antibodies may bring researchers a step closer to creating an effective HIV vaccine, according to a new paper co-authored by scientists at the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
Sweet -- sugared polymer a new weapon against allergies and asthma
Scientists at Johns Hopkins and their colleagues have developed sugar-coated polymer strands that selectively kill off cells involved in triggering aggressive allergy and asthma attacks.
Scientists visualize how bacteria talk to one another
Using imaging mass spectrometry, researchers at the University of California, San Diego have developed tools that will enable scientists to visualize how different cell populations of cells communicate.
Key player identified in cascade that leads to hypertension-related kidney damage
A key player in a cascade that likely begins with stress and leads to high blood pressure and kidney damage has been identified by researchers who say the finding may lead to better ways to control both.
Genetic links to fungal infection risk identified
Two genetic mutations that may put individuals at increased risk of fungal infections have been identified by scientists from UCL and Radboud University, increasing understanding about the genetic basis of these infections and potentially aiding the development of new treatments.
Study shows how carbon nanotubes can affect lining of the lungs
Carbon nanotubes are being considered for use in everything from sports equipment to medical applications, but a great deal remains unknown about whether these materials cause respiratory or other health problems.
Manipulating Brain Inflammation May Help Clear Brain of Amyloid Plaques, Mayo Clinic Researchers Say
In a surprising reversal of long-standing scientific belief, researchers at the Mayo Clinic campus in Florida have discovered that inflammation in the brain is not the trigger that leads to buildup of amyloid deposits and development of Alzheimer's disease.
Stanford study identifies cellular mechanism that causes lupuslike symptoms in mice
Macrophages, the scavenger cells of the body's immune system, are responsible for disposing of dying cells. Stanford University School of Medicine researchers have identified one pathway in this important process in mice that, if disrupted, causes a lupuslike autoimmune disease.
New chromosomal abnormality identified in leukemia associated with Down syndrome
Researchers identified a new chromosomal abnormality in acute lymphoblastic leukemia (ALL) that appears to work in concert with another mutation to give rise to cancer. This latest anomaly is particularly common in children with Down syndrome.
More Immune Cells Current Events and Immune Cells News Articles
 |
Mechanisms of Lymphocyte Activation and Immune Regulation XI: B Cell Biology (Advances in Experimental Medicine and Biology) (v. 11) by Sudhir Gupta (Editor), Frederick W. Alt (Editor), Max D. Cooper (Editor), Fritz Melchers (Editor), Klaus Rajewsky (Editor) In recent years, major developments have been made in understanding various genetic and epigenetic regulatory processes that are critical for the generation of B cell repertoires. These include the role of chromatin regulation and nuclear organization in understating the IgH gene regulation. A role and mechanism of DNA repair proteins in somatic hypermutation has been elucidated. Genetic mutation studies have been instrumental in providing insight into some of the mechanisms involved in targeting CSR to various switch DNA regions located upstream of C region genes, especially a role of AID motifs, transcription, and R-loops. Recent studies support a dominant role of receptor editing in central B cell tolerance and signaling pathways that regulate receptor editing in self-reactive and... |
 |
Nutravex Multi-Mineral Complex Immune and cell Defense Support Health & Wellness 64 Tablets by Nutravex Nutravex (ORAC Vit Complex), is a proprietary pharmaceutical grade nutraceutical comprised of a balanced, high-potency blend of 39 essential vitamins, antioxidants, and other important nutrients to support cellular metabolism and to counteract free-radical damage. |
 |
Source Naturals Nk-3 Immune Capsules, With Vitamin C, 250mg, 30-Count Bottle by Source Naturals NK-3 IMMUNE with vitamin C supports numerous natural immune processes, activating the work of macrophages, T cells, B cells, and natural killer or NK cells, the body¿s ¿first line of defense.¿ It stimulates the production of the chemical messengers that activate the body¿s natural immune response and it also supports a healthy circulatory system. |
 |
Natural C-Cap Formula - Maintains overall cell health and supports your pets immune system Buy 2, Get 1 Free by PetAlive What are C-Caps? C-Caps contain a combination of especially selected herbs known for their immune tonic properties, ability to support vitality and health, and for their cleansing and purifying actions. Each supports health in all cells, tissues, and organs in the body. Many of these herbs have been used for centuries in traditional medicine and subjected to clinical research. |
 |
PAW PAW CELL-REG (120) by Nature's Sunshine Products Paw Paw Cell-Reg selectively targets specific cells to enhance the overall health of the body. Paw Paw twigs contains acetogenins active compounds that modulate the production of ATP in mitochondria of specific cells, which affects the viability of specific cells and the growth of blood vessels that nourish them. A recent clinical study with over 100 participants showed that the paw paw extract, containing a mixture of acetogenins, supports the body's normal cells during times of cellular stress. Paw Paw Cell-Reg is a valuable tool in strengthening and supporting the immune system. This patent-pending product is the only standardized acetogenin product available to regulate specific cells. |
 |
The Human Body: How We Fail, How We Heal Also With: Anthony A. Goodman (Primary Contributor) 12 lectures/30 minutes per lecture on 2 DVDs. Part 1 only of 2 parts. |
|
Cancer and the Immune System : Cell-to-Cell Communication, An Introduction (31 minute colour VHS video) (NTSC video) by Spektrum Videothek Produced in Germany. In English. "This documentary focuses on... findings in immunilogical research." | |
 |
Antiox-10, 90 Capsules by Vetri-Science A supplement for dogs to support immune system and circulatory functions, and skin health. ANTIOX, grape seed extract supplement is standardized to yield 95% proanthocyanidins (PCOs) per capsule. PCOs are a special class of water-soluble bioflavonoids that are potent antioxidants. In some comparative tests, PCOs were found to be 50 times more potent than Vitamin E and 20 times more potent than Vitamin C as antioxidants. PCOs normalize the release of histamine from mast cells. PCOs support capillary strength. Weak capillaries can contribute to bruising, elastin and collagen dysfunction, edema, and circulatory insufficiencies. |
 |
Macrophages and Dendritic Cells: Methods and Protocols (Methods in Molecular Biology) by Neil E. Reiner (Editor) In light of the critical contributions of macrophages and dendritic cells to diverse inflammatory diseases and to immunity and host defense, state-of-the-art approaches to the investigation of their behavior are essential. In Macrophages and Dendritic Cells: Methods and Protocols, expert researchers contribute laboratory protocols involving these two vital cell types functioning at the junction of the innate and acquired immune systems. The volume delves first into isolation and cell culturing then continues with topics such as phagocytosis, genetic manipulation, macrophage activation, and lipid signaling. Written in the highly successful Methods in Molecular Biologyâ„¢ series format, chapters include brief introductions to their respective subjects, lists of the necessary materials... |
 |
The Extra Edge: Benefits of Immune-enhancing Enteral Formulas Also With: Novartis (Producer) Immune-enhancing enteral formulas provide critically ill patients with the extra edge that promotes their natural immunity. Clinical studies show that using a unique combination of three immune-enhancing nutrients: arginine, omega-3 fatty acids and dietary nucleotides-- results in fewer infectious complications, fewer days on a ventilator and shorter hospital stays. These enteral formulas can provide a significant impact on patient morbidity and overall health costs. |
| © 2009 BrightSurf.com |